Ružić, Maja
Type
Fulltext
Results 1-4 of 4 (Search time: 0.002 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 1-Dec-2018 | Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy | Maja Ružić ; Milotka Fabri; Tomislav Preveden ; Katarina Bačulov ; Maria Pete ; Anja Stojšin |
| 2 | 1-Jan-2017 | Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferonalpha and ribavirin - A prospective study | Maja Ružić ; Milotka Fabri; Milica Medić Stojanoska ; Ivana Bajkin ; Vesna Turkulov ; Ludovico Abenavoli |
| 3 | 1-Jan-2010 | Efficacy of combined antiviral therapy with pegylated interferon α-2a and ribavirin for chronic hepatitis C infection in intravenous drug users | Maja Ružić ; Milotka Fabri; Biljana Klašnja; Marta Pobor; Daniela Marić ; Aleksandra Jovelić; Isambela Fabri Galambos |
| 4 | 1-Jan-2013 | Treatment of chronic hepatitis C in injecting drug users - A 5-year follow-up | Maja Ružić ; Milotka Fabri; Tomislav Preveden ; Katarina Kiralj; Sandra Stefan Mikić ; Tatjana Vukadinov |